CLINICAL_TRIALS
trial_result
· 2022-03-11
Clinical Trial Update: Memantine for Epileptic Encephalopathy [Phase 4]
Summary
Phase 4 trial update for memantine in epileptic encephalopathy (childhood-onset) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kenneth Myers, MD | Conditions: Epileptic Encephalopathy, Childhood-Onset | Phase 4 | Status: COMPLETED